These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 18179309)

  • 1. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R; Salviati M; Fiorentini S; Biondi M
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.
    Zoccali R; Muscatello MR; Cedro C; Neri P; La Torre D; Spina E; Di Rosa AE; Meduri M
    Int Clin Psychopharmacol; 2004 Mar; 19(2):71-6. PubMed ID: 15076014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.
    Cho SJ; Yook K; Kim B; Choi TK; Lee KS; Kim YW; Lee JE; Suh S; Yook KH; Lee SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):208-11. PubMed ID: 21095214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
    Henderson DC; Goff DC
    J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
    Munro J; Matthiasson P; Osborne S; Travis M; Purcell S; Cobb AM; Launer M; Beer MD; Kerwin R
    Acta Psychiatr Scand; 2004 Oct; 110(4):292-8. PubMed ID: 15352931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW; Lee JG; Lee BJ; Kim YH
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunct mirtazapine for negative symptoms of schizophrenia.
    Phan SV; Kreys TJ
    Pharmacotherapy; 2011 Oct; 31(10):1017-30. PubMed ID: 21950644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
    Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
    Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia--a path model investigation.
    Stenberg JH; Terevnikov V; Joffe M; Tiihonen J; Chukhin E; Burkin M; Joffe G
    Neuropharmacology; 2013 Jan; 64():248-53. PubMed ID: 22750079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
    Jalenques I; Coudert AJ
    Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia.
    Stenberg JH; Terevnikov V; Joffe M; Tiihonen J; Tchoukhine E; Burkin M; Joffe G
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1080-6. PubMed ID: 21402120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial.
    Terevnikov V; Stenberg JH; Joffe M; Tiihonen J; Burkin M; Tchoukhine E; Joffe G
    Hum Psychopharmacol; 2010 Aug; 25(6):431-8. PubMed ID: 20737516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
    Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
    J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.